Loading...
Loading...
INVO| Name | Value |
|---|---|
| Revenues | 315.9K |
| Cost of Revenue | 255.4K |
| Gross Profit | 60.5K |
| Operating Expense | 2,126.5K |
| Operating I/L | -2,066.0K |
| Other Income/Expense | -171.7K |
| Interest Income | 175.2K |
| Pretax | -2,237.6K |
| Income Tax Expense | 2.9K |
| Net Income/Loss | -2,240.5K |
INVO Bioscience, Inc. is a commercial-stage fertility company specializing in assisted reproductive technology solutions. Its flagship product, the INVOcell, is a medical device that facilitates fertilization and early embryo development within the woman's body. The company generates revenue by providing this innovative technology to fertility clinics and healthcare facilities worldwide.
